Luis Diaz-Rangel

Clinical trials

• A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  Site PI · Recruiting · Phase 3

  Takeda

  2026–2034
• The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

  Site PI · Recruiting

  Luminate Medical, Inc.

  2025–2026
• Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

  Site PI · Recruiting · Phase 2, Phase 3

  Beijing Biostar Pharmaceuticals Co., Ltd.

  2025–2030
• A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  Site PI · Recruiting · Phase 3

  UroGen Pharma Ltd.

  2025–2028